NCT06954077View on ClinicalTrials.gov

A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

December 31, 2027

Conditions
Gastrointestinal TumorSolid Tumor
Interventions
DRUG

BL-M09D1

Administration by intravenous infusion for a cycle of 3 weeks.

Trial Locations (1)

Unknown

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
collaborator

Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

INDUSTRY

lead

Sichuan Baili Pharmaceutical Co., Ltd.

INDUSTRY